Company news

Aurora Cannabis Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Aurora Names Seasoned Global CPG Executive to Lead Australia and New Zealand

December 8, 2025

Aurora Announces Distribution Partnership with Leafio Australia

December 2, 2025

Aurora Cannabis Announces Fiscal 2026 Second Quarter Results

November 5, 2025

Aurora Cannabis to Host Second Quarter 2026 Investor Conference Call

October 22, 2025

Aurora Announces Investment into German Manufacturing Facility

September 18, 2025

Aurora and Copeia Launch English Version of Physician Experience Platform (PEP), Expanding Access to Peer-Reviewed Medical Cannabis Case Studies

September 9, 2025

Aurora, a Leading Global Medical Cannabis Company, Attends the H.C. Wainwright 27th Annual Global Investment Conference

September 8, 2025

Aurora Ignites Global Expansion with Whistler Cannabis Co. Brand Debut in Australia

August 12, 2025

Aurora Cannabis Inc. Announces Results of 2025 Annual General and Special Meeting

August 8, 2025

Aurora to Participate in Canaccord Genuity 45th Annual Growth Conference

August 7, 2025

Aurora Cannabis Announces Fiscal 2026 First Quarter Results

August 6, 2025

Aurora Cannabis Inc. Reminds Shareholders to Vote in Advance of the Proxy Voting Deadline for its 2025 Annual General and Special Meeting of Shareholders

July 30, 2025

Aurora Cannabis to Host First Quarter 2026 Investor Conference Call

July 23, 2025

Aurora Continues Deep Commitment to Veterans Through Strains for Heroes Initiative

July 16, 2025

Aurora Completes First-Ever EU-GMP Certification for the Company's Dedicated Distribution Centre

July 14, 2025

Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General and Special Meeting of Shareholders

July 9, 2025

Aurora Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program

June 26, 2025

Aurora Sets New Standard in Poland with the Launch of Two High Potency Flower Products

June 24, 2025

Aurora Cannabis Advises of Second False Article from Investing.com

June 19, 2025

Aurora Cannabis Denies News of Acquisition of MedLeaf Therapeutics

June 18, 2025

Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter

June 18, 2025

Aurora Expands Medical Cannabis Offerings in Australia with the Launch of IndiMed TEMPO 22

June 5, 2025

Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2025 Investor Conference Call and File Related Year End Information

June 3, 2025

Aurora to Participate in TD Cowen's 9th Annual Future of the Consumer Conference

May 27, 2025

Aurora Cannabis Announces the Completion of a Multimillion Dollar Investment and Renaming of B.C. Manufacturing Facility

April 30, 2025

Aurora Cannabis Introduces the Company's First Inhalable Resin Cartridges for Patients in the United Kingdom

April 15, 2025

Aurora Cannabis Recognized for Executive Gender Diversity by The Globe and Mail

March 31, 2025

Aurora Cannabis to Speak at the Global Cannabis Regulatory Summit

March 25, 2025

Aurora Cannabis Announces Breakthrough Discovery of Powdery Mildew Resistant Cultivars

March 20, 2025

Aurora Cannabis Expands Medical Cannabis Pastille Offerings in Australia

February 20, 2025

Breaking Down Barriers: Aurora Cannabis Eases Patient Access to High Quality Medical Cannabis Products in Australia

February 14, 2025

Aurora Cannabis Announces Supply Agreement with SNDL

February 6, 2025

Aurora Cannabis Announces Fiscal 2025 Third Quarter Results

February 5, 2025

Aurora Cannabis Launches First Domestically Grown Medical Cannabis Brand in Germany Under New Cultivation License

January 23, 2025

Aurora Cannabis to Host Third Quarter 2025 Investor Conference Call

January 22, 2025

Empowering the Next Generation: Aurora Announces German Internship Program

January 10, 2025

Aurora Announces Distribution Partnership Between MedReleaf Australia and The Entourage Effect

December 17, 2024

Aurora Announces Medical Product Advancements from Leading Cannabis Research Facility

November 26, 2024

Aurora Cannabis Expands Innovative Recreational Product Portfolio

November 20, 2024

Aurora Cannabis Announces Fiscal 2025 Second Quarter Results

November 6, 2024

Aurora Cannabis to Host Second Quarter 2025 Investor Conference Call

October 24, 2024

Aurora Introduces Innovative Cannabis Oil Range to Meet Diverse Patient Needs in Australia

October 16, 2024

Aurora Cannabis Announces Collaboration on Genome BC-Funded Project Addressing Distinct Cannabis Aromas

October 2, 2024

Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors

September 20, 2024

Aurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Future Cultivation Excellence

September 17, 2024

Aurora Cannabis and Vectura Fertin Pharma, Inc. announce launch of novel Luo CBD lozenge

September 9, 2024

Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting

August 12, 2024

Aurora Cannabis Announces Fiscal 2025 First Quarter Results and Delivers Positive Free Cash Flow

August 7, 2024

Aurora Cannabis and Vectura Fertin Pharma, Inc. announce commercial collaboration

August 1, 2024

Aurora Cannabis Inc. Reminds Shareholders to Vote in Advance of the Proxy Voting Deadline for its 2024 Annual General and Special Meeting of Shareholders

July 30, 2024

← Newer news releases · Older news releases →

Calls

The 5 newest of 27 calls. Every call is listed under its year.

Decks

The 5 newest of 18 decks. Every deck is listed under its year.